METHOD FOR ASSESSING LYMPH NODE METASTATIC POTENTIAL OF ENDOMETRIAL CANCER

Provided is an approach for discriminating endometrial cancer at a molecular level between endometrial cancer with lymph node metastasis and that without metastasis. A method for assessing lymph node metastasis or lymph node metastatic potential of endometrial cancer, comprising the step of measurin...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	MIYAGI, Yohei, HAYASHIZAKI, Yoshihide, ITO, Masayoshi, OOMIYA, Hiroko, KATO, Hisamori, TERAO, Yasuhisa, TAKEDA, Satoru, KAWAJI, Hideya, OHTSU, Takashi
Format:	Patent
Sprache:	eng ; fre ; ger
Schlagworte:	BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS OR TEST PAPERS THEREFOR COMPOSITIONS THEREOF CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES CULTURE MEDIA ENZYMOLOGY MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING PROCESSES OF PREPARING SUCH COMPOSITIONS PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPIRITS VINEGAR WINE
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Provided is an approach for discriminating endometrial cancer at a molecular level between endometrial cancer with lymph node metastasis and that without metastasis. A method for assessing lymph node metastasis or lymph node metastatic potential of endometrial cancer, comprising the step of measuring an expression level of an expression product of at least one DNA comprising a transcription start site in a biological sample derived from a cancer tissue isolated from an endometrial cancer patient, wherein the DNA comprises a base at an arbitrary position in the transcription start site in any of nucleotide sequences represented by SEQ ID NOs: 1 to 277 and at least one or more bases located immediately downstream thereof, and the transcription start site is a region wherein both ends thereof are defined by the first base in any of the nucleotide sequences represented by SEQ ID NOs: 1 to 277 and the 101st base counted from the 3' end.